Aflac (AFL)
(Delayed Data from NYSE)
$83.73 USD
-0.55 (-0.65%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $83.72 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$83.73 USD
-0.55 (-0.65%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $83.72 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Zacks News
Aflac Incorporated was formed in 1973 under the laws of the state of Georgia. The company is a general business holding company and oversees the operations of its subsidiaries by providing management services and making capital available. Its principal business is voluntary supplemental and life insurance, which is marketed and administered through American Family Life Assurance Company of Columbus (Aflac) in the United States (Aflac U.S.) and, effective Apr 1, 2018, through Aflac Life Insurance Japan Ltd. in Japan (Aflac Japan).
Trupanion (TRUP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synchrony (SYF) Q1 Earnings Miss on Low Net Interest Margin
by Zacks Equity Research
Synchrony's (SYF) quarterly results suffer from higher expenses and provision for credit losses. However, rising loan receivables portfolio and robust purchase volume partially offset the negatives.
Aflac (AFL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Aflac (AFL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Stocks From the Prospering Accident & Health Insurance Industry
by Tanuka De
Lower claims frequency, moderate pricing and the adoption of technology are likely to boost the performance of Zacks Accident and Health Insurance industry players like AFL, UNM, EIG, AMSF and TRUP.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Aflac (AFL) have what it takes? Let's find out.
Want Better Returns? Don?t Ignore These 2 Finance Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Aflac (AFL) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Aflac (AFL) have what it takes? Let's find out.
Here's Why Prudent Investors are Holding Aflac (AFL) Shares Now
by Zacks Equity Research
Higher net investment income, an improved expense ratio and enhanced profit levels from the U.S. business poise Aflac (AFL) well for growth.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Aflac (AFL) have what it takes? Let's find out.
Why Is Aflac (AFL) Up 6% Since Last Earnings Report?
by Zacks Equity Research
Aflac (AFL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Exploring the Driving Forces Behind eHealth's (EHTH) Q4 Earnings
by Zacks Equity Research
eHealth's (EHTH) fourth-quarter 2023 results are likely to reflect higher expenses and Individual, Family and Small Business segment revenues.
Why Aflac (AFL) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Aflac (AFL) have what it takes? Let's find out.
Will Higher Expense Ratio Hurt ProAssurance's (PRA) Q4 Earnings?
by Zacks Equity Research
ProAssurance's (PRA) fourth-quarter results are likely to reflect lower net premiums earned and a higher expense ratio.
Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for NOBL
Will Higher Expenses Hurt AMERISAFE's (AMSF) Q4 Earnings?
by Zacks Equity Research
AMERISAFE's (AMSF) fourth-quarter results are likely to reflect flat audit premiums and higher expenses.
Spotlight on Employers Holdings' (EIG) Q4 Earnings Drivers
by Zacks Equity Research
Employers Holdings' (EIG) fourth-quarter 2023 results are likely to reflect higher expenses and net premiums earned.
Can Corebridge (CRBG) Q4 Earnings Beat on Investment Income?
by Zacks Equity Research
Corebridge's (CRBG) fourth-quarter results are likely to reflect increasing Group Retirement fee income.
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Philip Morris, General Dynamics, Becton, Dickinson, Cheniere Energy and Aflac
by Zacks Equity Research
Thermo Fisher Scientific, Philip Morris, General Dynamics, Becton, Dickinson, Cheniere Energy and Aflac are included in this Analyst Blog.
Earnings Season Scorecard and Analyst Reports for Thermo Fisher, Philip Morris & General Dynamics
by Sheraz Mian
Today's Research Daily features the real-time earnings season scorecard and updated analyst reports on Thermo Fisher (TMO), Philip Morris International (PM) and General Dynamics (GD).
Down -7.13% in 4 Weeks, Here's Why You Should You Buy the Dip in Aflac (AFL)
by Zacks Equity Research
Aflac (AFL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Aflac's (AFL) Q4 Earnings Miss on Higher Benefits and Claims
by Zacks Equity Research
Aflac (AFL) expects to exceed $1.8 billion in sales in the United States by 2025.
Is Aflac (AFL) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Aflac (AFL) and American Express (AXP) have performed compared to their sector so far this year.
Aflac (AFL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Aflac (AFL) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Aflac (AFL) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Aflac (AFL) delivered earnings and revenue surprises of -14.97% and 14.97%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
4 Accident & Health Insurers to Watch as Underwriting Exposure Increases
by Tanuka De
Lower claims frequency, moderate pricing and the adoption of technology are likely to boost the performance of the Zacks Accident and Health Insurance industry players like AFL, UNM, EIG and TRUP.